WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease ...Middle East

WUXI, China, Oct. 2, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner, Amicus Therapeutics ("Amicus") (Nasdaq: FOLD), on receiving U.S. FDA's approval for...

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease )

Also on site :

• Exactly How Many Times a Week To Walk To Improve Your Heart Health, According to Cardiologists
• Olivia Rodrigo Sends Fans Into ‘Fever Dream’ Twinning With ‘80s Icon, 73, Onstage: ‘Such an Unexpected Duo’
• Legendary Actor Speaks Out After Being Swarmed by TSA Officers